Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Cell Therapy in Patients With Covid-19 Using Wharton’S Jelly Mesenchymal Stem Cells: A Phase 1 Clinical Trial
Ahmadreza Niavarani
Ahmadreza Niavarani

Associate Professor of Biologic Products

Shariati Hospital

Digestive Diseases Research Center

Tehran University of Medical Sciences

All Documents
1. Genome-Wide Association Study of Long Covid, Nature Genetics (2025)
2. The Role of Distinct Apobec/Adar Mrna Levels in Mutational Signatures Linked to Aging and Ultraviolet Radiation, Scientific Reports (2024)
3. A First Update on Mapping the Human Genetic Architecture of Covid-19, Nature (2022)
4. Molecular Dynamics Analysis Predicts Ritonavir and Naloxegol Strongly Block the Sars-Cov-2 Spike Protein-Hace2 Binding, Journal of Biomolecular Structure and Dynamics (2022)
5. Seroprevalence of Sars-Cov-2 Antibody Among Urban Iranian Population: Findings From the Second Large Population-Based Cross-Sectional Study, BMC Public Health (2022)
6. The Long-Term Outcome and Efficacy of Pr1/Bcr-Abl Multipeptides Vaccination in Chronic Myeloid Leukemia: Results of a 7-Year Longitudinal Investigation, Iranian Journal of Blood and Cancer (2022)
7. Whole-Genome Sequencing Reveals Host Factors Underlying Critical Covid-19, Nature (2022)
8. Dynamics of the Covid-19 Clinical Findings and the Serologic Response, Frontiers in Microbiology (2021)
9. Mutational Signatures in Esophageal Squamous Cell Carcinoma From Eight Countries With Varying Incidence, Nature Genetics (2021)
10. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
11. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
12. Pancancer Analysis Identifies Prognostic High-Apobec1 Expression Level Implicated in Cancer In-Frame Insertions and Deletions, Carcinogenesis (2018)
13. A 4-Gene Expression Score Associated With High Levels of Wilms Tumor-1 (Wt1) Expression Is an Adverse Prognostic Factor in Acute Myeloid Leukaemia, British Journal of Haematology (2016)
14. The Wilms Tumor-1 (Wt1) Rs2234593 Variant Is a Prognostic Factor in Normal Karyotype Acute Myeloid Leukemia, Annals of Hematology (2016)
15. Apobec3a Is Implicated in a Novel Class of G-To-A Mrna Editing in Wt1 Transcripts, PLoS ONE (2015)